Hardiman Roy C.
Insider CIK 1506218 · PRNB Chief Business Officer · ALMS Chief Business & Strategy Ofcr · PCYC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,692 | $26.37 | $71.0K | 207,746 | SEC↗ |
| ALMS ALUMIS INC. | S Sale | 2026-08-03 | 2026-08-05 | 2,692 | $26.37 | $71.0K | 207,746 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2026-01-26 | 2026-01-28 | 190,875 | — | $0 | 190,875 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-07-29 | 2025-07-31 | 111,950 | — | $0 | 111,950 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2025-07-29 | 2025-07-31 | 28,000 | — | $0 | 206,401 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2025-02-18 | 2025-02-20 | 140,000 | — | $0 | 140,000 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 30,642 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 30,642 | — | $0 | 30,642 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 206,074 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 206,074 | — | $0 | 206,074 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 53,475 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 53,475 | — | $0 | 53,475 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 151,871 | — | $0 | 151,871 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 151,871 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 42,780 | — | $0 | 42,780 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 42,780 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award deriv | 2024-07-01 | 2024-07-01 | 14,973 | — | $0 | 14,973 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer deriv | 2024-07-01 | 2024-07-01 | 14,973 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 175,401 | — | $0 | 175,401 | SEC↗ |
| ALMS ALUMIS INC. | A Award | 2024-07-01 | 2024-07-01 | 6,417 | — | $0 | 6,417 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 6,417 | — | $0 | 0 | SEC↗ |
| ALMS ALUMIS INC. | D To issuer | 2024-07-01 | 2024-07-01 | 175,401 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 60,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 44,034 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 55,000 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | D To issuer deriv | 2020-09-28 | 2020-09-28 | 11,519 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 1,916 | $100.00 | $191.6K | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | U Tender | 2020-09-28 | 2020-09-28 | 117,761 | $100.00 | $11.78M | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-09-18 | 2020-09-22 | 2,242 | — | $0 | 11,519 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-09-18 | 2020-09-22 | 2,758 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-09-18 | 2020-09-22 | 5,000 | $99.98 | $499.9K | 117,761 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-09-18 | 2020-09-22 | 2,242 | $7.27 | $16.3K | 122,761 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-09-18 | 2020-09-22 | 2,758 | $4.72 | $13.0K | 120,519 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-06-12 | 2020-06-15 | 5,000 | — | $0 | 2,758 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-12 | 2020-06-15 | 863 | $62.13 | $53.6K | 117,761 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-06-12 | 2020-06-15 | 5,000 | $4.72 | $23.6K | 122,761 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-12 | 2020-06-15 | 1,595 | $59.90 | $95.5K | 121,166 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-06-12 | 2020-06-15 | 2,542 | $61.62 | $156.6K | 118,624 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2020-03-13 | 2020-03-17 | 5,000 | — | $0 | 7,758 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-13 | 2020-03-17 | 100 | $51.04 | $5.1K | 116,903 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2020-03-13 | 2020-03-17 | 5,000 | $4.72 | $23.6K | 121,903 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-13 | 2020-03-17 | 3,719 | $48.21 | $179.3K | 118,184 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2020-03-13 | 2020-03-17 | 1,181 | $49.46 | $58.4K | 117,003 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2020-03-05 | 2020-03-05 | 55,000 | — | $0 | 55,000 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-12-13 | 2019-12-13 | 871 | — | $0 | 12,758 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise deriv | 2019-12-13 | 2019-12-13 | 4,129 | — | $0 | 0 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-13 | 2019-12-13 | 1,619 | $49.83 | $80.7K | 120,143 | SEC↗ |
| PRNB Principia Biopharma Inc. | S Sale | 2019-12-13 | 2019-12-13 | 3,381 | $49.20 | $166.3K | 121,762 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-12-13 | 2019-12-13 | 4,129 | $5.00 | $20.6K | 125,143 | SEC↗ |
| PRNB Principia Biopharma Inc. | M Exercise | 2019-12-13 | 2019-12-13 | 871 | $4.72 | $4.1K | 121,014 | SEC↗ |
| PRNB Principia Biopharma Inc. | A Award deriv | 2019-03-01 | 2019-03-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-10-01 | 2012-10-03 | 409 | — | $0 | 409 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-07-02 | 2012-07-05 | 453 | — | $0 | 453 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-04-02 | 2012-04-04 | 802 | — | $0 | 802 | SEC↗ |
| PCYC PHARMACYCLICS INC | A Award deriv | 2012-01-03 | 2012-01-05 | 1,963 | — | $0 | 1,963 | SEC↗ |